CHRONIC WEIGHT MANAGEMENT Novo Nordisks oral semaglutide ( which may be marketed as Rybelsus at an anticipated higher dose or rebranded with a new name for weight management use ) is pending approval for chronic weight management (CWM) in Q4 of 2025
Understanding gallstones and weight loss UK prevalence and statistics Gallstones are remarkably common in the UK, affecting approximately 10-15% of adults 2
Deze combinatie van bereikbaarheid, deskundigheid en persoonlijke zorg maakt Van Laar Clinic een vertrouwde keuze voor iedereen die op een veilige, professionele manier wil werken aan duurzame gezondheidsverbetering
Research shows that essential oil plays an important role in the process of plants dealing with pests, fungi, and bacteria (HarkatMadouri et al., 2015)
Anyone starting or continuing a compounded GLP-1 program right now should understand the FDA's April 2026 proposal, ask their telehealth platform about pharmacy structure, and have a conversation with their clinician about contingency planning for their care if compounding availability changes
C., Watts, G